Cargando…
B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vivo
BACKGROUND: Osteosarcoma (OS) mainly happens in children and youths. Surgery, radiotherapy and chemotherapy are the common therapies for osteosarcoma treatment but all their anti-tumor effects are limited. In recent years, a new cellular therapy, CAR-T, a cellular immunotherapy with genetically engi...
Autores principales: | Zhang, Qian, Zhang, Zhiqiang, Liu, Guodi, Li, Dehua, Gu, Zhangjie, Zhang, Linsong, Pan, Yingjiao, Cui, Xingbing, Wang, Lu, Liu, Guoping, Tian, Xiaoli, Zhang, Ziming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628043/ https://www.ncbi.nlm.nih.gov/pubmed/36320072 http://dx.doi.org/10.1186/s12885-022-10229-8 |
Ejemplares similares
-
The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
por: Zhang, Qian, et al.
Publicado: (2021) -
Chimeric Antigen receptor-T (CAR-T) cells targeting Epithelial cell adhesion
molecule (EpCAM) can inhibit tumor growth in ovarian cancer mouse model
por: FU, Juan, et al.
Publicado: (2020) -
Doctors' Cars at the Motor Show
Publicado: (1908) -
Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis
por: Liu, Xueyong, et al.
Publicado: (2017) -
Switchable CAR T cell strategy against osteosarcoma
por: Hidalgo, Laura, et al.
Publicado: (2023)